Remepy
Raz Vakil is an accomplished professional in the field of artificial intelligence and machine learning, currently serving as the Head of Artificial Intelligence at Remepy since June 2025. Prior to this role, Raz held various positions at Taboola from January 2014 to June 2025, including Algorithms Group Manager, where management of a 15-person algorithms group focused on optimizing algorithmic performance, and Algorithms Team Lead, overseeing a team of data scientists working on content recommendations. Raz began career as an Algorithms Developer at Taboola and previously contributed as an Algorithm Developer at XTR and a Senior Software Developer at Dell. Early experience includes serving as a Cryptographer in the Israel Defense Forces. Raz holds a PhD in Applied Mathematics from The Hebrew University of Jerusalem and a Master’s degree in Applied Mathematics from Bar-Ilan University.
This person is not in any teams
This person is not in any offices
Remepy
Remepy is Pioneering Hybrid Drugs™. We believe that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs™. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™. Remepy’s Digital Molecules™ are designed to be the software components within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug. The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.